Amphastar Pharmaceuticals, Inc. (AMPH) SEC Filings — 2025
12 SEC filings for Amphastar Pharmaceuticals, Inc. (AMPH) in 2025.
Filings
- Amphastar's Q3 Net Income Plummets 57% Amid Soaring Expenses — 10-Q · Nov 6, 2025
- Amphastar Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 24, 2025
- Amphastar Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 18, 2025
- Amphastar Pharmaceuticals Enters Material Definitive Agreement — 8-K · Aug 12, 2025
- Amphastar Boosts Share Buybacks, Reports Steady Product Revenue — 10-Q · Aug 7, 2025
- Amphastar Pharmaceuticals Announces Board and Compensation Changes — 8-K · Jul 21, 2025
- Amphastar Pharmaceuticals Files 8-K on Corporate Matters — 8-K · Jun 4, 2025
- Amphastar Pharmaceuticals Files 10-Q for Q1 2025 — 10-Q · May 8, 2025
- Amphastar Pharmaceuticals Files 8-K — 8-K · May 7, 2025
- Amphastar Pharma Files 2024 Proxy Statement — DEF 14A · Apr 14, 2025
- Amphastar Pharmaceuticals Files 2024 10-K — 10-K · Mar 3, 2025
- Amphastar Pharmaceuticals Files 8-K on Financials — 8-K · Feb 27, 2025